Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With AF

Post time 2024-4-12 20:40:58

journal：Circulation

Authors：Siddharth M. Patel; Eugene Braunwald; Jan Steffel; Giuseppe Boriani; Michael G. Palazzolo; Elliott M. Antman; Erin A. Bohula; Anthony P. Carnicelli; Stuart J. Connolly; John W. Eikelboom; Baris Gencer; Christopher B. Granger; David A. Morrow; Manesh R. Patel; Lars Wallentin; Christian T. Ruff; Robert P. Giugliano;

Published date：2024-3-19

DOI：10.1161/circulationaha.123.066279

PDF link：https://www.ahajournals.org/doi/ ... ATIONAHA.123.066279

Article link：http://dx.doi.org/10.1161/circulationaha.123.066279

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

Post time 2024-4-12 20:40:59

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AHA] Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With AF

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With AF Copy

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today

[AHA] Efficacy and Safety of Non–Vitamin-K Antagonist Oral Anticoagulants Versus Warfarin Across the Spectrum of Body Mass Index and Body Weight: An Individual Patient Data Meta-Analysis of 4 Randomized Clinical Trials of Patients With AF